AINDEX
Markets

Vivos Therapeutics, Inc. (VVOS)

VVOSNASDAQ-CMMedical/Dental Instruments

$0.0950

+0.0013 (+1.39%) today

Closed, Nov 9, 4:00 PM ET

+1.39% 1D
Market cap
$3.22m
P/E
–
EPS, last 4 quarters
$-1.90
Dividend yield
–
Day range
–
52-week range
$0.0920 to $2.72
Average volume
17.38m
Previous close
$0.0937

Earnings

next estimate $-0.3000

Next report Nov 18, 2026

Sep 2025

+7.5%

Dec 2025

–

Mar 2026

-15.6%

Jun 2026

+26.2%

estimate reported, and the surprise

Financials

QuarterSep 2025Dec 2025Mar 2026Jun 2026
Revenue$6.78m$3.82m$5.14m$5.15m
Gross profit$3.94m$2.99m$3.06m$2.95m
Operating income-$4.73m-$6.38m-$6.62m-$4.83m
Net income-$5.40m-$6.89m-$7.68m-$5.48m

Last four quarters: revenue $20.90m, margin -121.8%, free cash flow -$19.01m

News

8 latest

The company

Vivos Therapeutics, Inc. (Nasdaq: VVOS) is a medical technology company focused on developing and commercializing innovative treatments for patients with sleep-disordered breathing, including obstructive sleep apnea. Its FDA-cleared oral appliances offer a non-surgical, non-invasive alternative to CPAP. For more information, visit www.vivos.com.

Sector
Health Care
Industry
Medical/Dental Instruments
Exchange
NASDAQ-CM
Region
North America
Website
vivos.com

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.

Vivos Therapeutics, Inc. (VVOS) price, chart and news · AINDEX